Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Latvijas Finieris is a prominent Latvian wood processing company and a global leader in birch plywood production, primarily operating under the brand name Riga Wood. While its core business serves the construction and industrial sectors, the company has strategically diversified into the life sciences through the extraction of high-value bioactive compounds from birch bark. Its dedicated extraction facility produces pharmaceutical-grade betulin and suberin, which are utilized in the development of anti-inflammatory, anti-viral, and cholesterol-lowering products. By leveraging its vast forestry resources, Latvijas Finieris provides raw materials for the pharmaceutical, cosmetic, and nutraceutical industries. The company is recognized for its commitment to the circular economy and its collaboration with research institutions to advance wood-based chemical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Latvijas Finieris.